Literature DB >> 21831415

A novel mutation in CD132 causes X-CID with defective T-cell activation and impaired humoral reactivity.

Taco W Kuijpers, Paul A Baars, Daan J Aan de Kerk, Machiel H Jansen, Ingrid A M Derks, Robbert G M Bredius, Elisabeth A M Sanders, Mirjam van der Burg, Marielle Alders, Rene A W van Lier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21831415     DOI： 10.1016/j.jaci.2011.07.001

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  4 in total

Review 1.  Advances in basic and clinical immunology in 2011.

Authors:  Javier Chinen; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2011-12-28       Impact factor: 10.793

2.  A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8+ T cells.

Authors:  Taco W Kuijpers; Ester M M van Leeuwen; Barbara H Barendregt; Paul Klarenbeek; Daan J aan de Kerk; Paul A Baars; Machiel H Jansen; Niek de Vries; René A W van Lier; Mirjam van der Burg
Journal:  Haematologica       Date:  2013-02-12       Impact factor: 9.941

3.  The IL-2RG R328X nonsense mutation allows partial STAT-5 phosphorylation and defines a critical region involved in the leaky-SCID phenotype.

Authors:  A Arcas-García; M Garcia-Prat; M Magallón-Lorenz; A Martín-Nalda; O Drechsel; S Ossowski; L Alonso; J G Rivière; P Soler-Palacín; R Colobran; J Sayós; M Martínez-Gallo; C Franco-Jarava
Journal:  Clin Exp Immunol       Date:  2020-01-19       Impact factor: 4.330

4.  Phenotypic and Functional Comparison of Class Switch Recombination Deficiencies with a Subgroup of Common Variable Immunodeficiencies.

Authors:  Daan J Aan de Kerk; Machiel H Jansen; Stephen Jolles; Klaus Warnatz; Suranjith L Seneviratne; Ineke J M Ten Berge; Ester M M van Leeuwen; Taco W Kuijpers
Journal:  J Clin Immunol       Date:  2016-08-02       Impact factor: 8.317
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.